Your browser doesn't support javascript.
loading
Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAFV600E mutated, microsatellite-stable colon cancer: A case report and literature review.
Piringer, Gudrun; Decker, Jörn; Trommet, Vera; Kühr, Thomas; Heibl, Sonja; Dörfler, Konrad; Thaler, Josef.
Affiliation
  • Piringer G; Department of Internal Medicine IV, Wels-Grieskirchen Medical Hospital, Wels, Austria.
  • Decker J; Department of Hematology and Oncology, Kepler University Hospital, Linz, Austria.
  • Trommet V; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Kühr T; Department of Internal Medicine, Klinikum Rohrbach, Rohrbach, Austria.
  • Heibl S; Department of Internal Medicine IV, Wels-Grieskirchen Medical Hospital, Wels, Austria.
  • Dörfler K; Department of Internal Medicine IV, Wels-Grieskirchen Medical Hospital, Wels, Austria.
  • Thaler J; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
Front Oncol ; 13: 1166545, 2023.
Article de En | MEDLINE | ID: mdl-37213293
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Front Oncol Année: 2023 Type de document: Article Pays d'affiliation: Autriche Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Front Oncol Année: 2023 Type de document: Article Pays d'affiliation: Autriche Pays de publication: Suisse